February 24, 2021 Transparency Market Research Publications
Transparency Market Research (TMR) released a new report titled, « Pediatric Health Products and Services Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018– 2026 « published. According to the report, the global pediatric health products and services market was estimated at USD 88,000 million and USD 520,000 million in 2017, and is expected to grow at an annual growth rate of 4.5% and 5.5% from 2018 to 2026, respectively . The rise in disorders and diseases in children is expected to drive demand for drugs to treat these conditions from 2018 to 2026. The increase in funding for research into pediatric diseases, particularly in countries like the US, UK and Germany, is expected to lead to new treatment options for the treatment of various diseases in children. The increasing number of children with disorders and diseases such as allergies, asthma and other respiratory diseases, high blood pressure, obesity, mental disorders and infectious diseases is driving the global market. In addition, raising children’s health awareness, increasing the number of programs to safeguard children’s interests and rights, and promoting children’s full development are expected to help improve children’s overall well-being and growth Children promote the market in the forecast period.
Countries around the world are working with industry to develop novel drugs that can address concerns arising from the resistance of microorganisms to antibiotics. These initiatives are expected to attract more investment in the development of new and improved drugs to combat antibiotic-resistant bacteria. Large pharmaceutical companies are focusing on new product launches and expanding the indications of existing drugs for pediatric patients to meet the large unmet need and then expand their market share. These factors are likely to accelerate the growth of the market over the forecast period. However, strict regulatory requirements are likely to constrain the market.
The report provides a detailed segmentation of the global Pediatric Health Products and Services Market by drug class, disease / disorder, and type of service. In terms of drug class, the antibiotics segment is expected to capture a large market share from 2018 to 2026. A significant market share of the segment is attributable to the high prescription rates for antibiotics in children and the propensity for self-medication, especially in low-income countries. The Antidepressants segment is expected to account for 4.0% market share by 2026 as more children and adolescents are affected by depression and anxiety worldwide.
Application to analyze the impact of COVID-19 on the pediatric health products and services market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=12236
The allergies and respiratory tract segment should account for the largest market share by 2026. The segment is expected to expand at a high rate of growth in the forecast period. The growth of the segment is due to the increasing demand for pediatric health products for allergies and respiratory diseases. The Hormonal Imbalances segment held a 4.0% market share in 2017.
The other segment of pediatric health services is expected to have a dominant share of the global market in the forecast period due to the increasing exposure to diseases and disorders such as infectious diseases, allergies, asthma and other respiratory diseases Occupy market for pediatric health care services and services among children. In addition, greater emphasis on newborn screening programs, which focus on detecting various health conditions in infants, is expected to spur growth in the segment from 2018 to 2026. North America had the largest share of the global in 2017 Pediatric Health Products and Services Market. A significant market share in the region is due to the introduction of new drugs by pharmaceutical companies targeting pediatric patients. The Asia-Pacific market is expected to grow at a significant CAGR over the forecast period, driven by the increase in the number of children with diseases and disorders and the improvement in health infrastructure in countries like China, India, and Indonesia.
The Report also includes profiles of leading players in the global Pediatric Health Products and Services Market. These include Pfizer, Inc., GlaxoSmithKline plc. Merck & Co., Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Gilead Sciences, Inc., Sanofi, Pediapharm, Inc., Novartis AG, Eisai Co., Ltd. and Mylan N.V.
Transparency Market Research is a global market research company that provides global business intelligence reports and services. Our exclusive mix of quantitative forecast and trend analysis offers several decision-makers forward-looking insights. Our experienced team of analysts, researchers and consultants uses proprietary data sources as well as various tools and techniques to collect and analyze information.
Our data repository is continuously updated and revised by a team of research experts to keep it up to date with the latest trends and trends Information reflects. Transparency Market Research has extensive research and analysis capabilities and uses rigorous primary and secondary research techniques to develop distinctive data sets and research materials for annual reports.
Medical technology is changing the world! Join in and see the progress in real time. At Medgadget, we have been reporting on the latest technology news, interviewing local leading companies, and archiving mailings of medical events around the world since 2004.
Ref: https://www.medgadget.com
